<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/201</identifier>
				<datestamp>2024-10-30T19:15:53Z</datestamp>
				<setSpec>aavptbiennial:S4</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Pharmacokinetics and Electrocardiographic Effects of Verapamil in the Cat</dc:title>
	<dc:creator xml:lang="en">Pion, P. D.</dc:creator>
	<dc:creator xml:lang="en">Babish, J.</dc:creator>
	<dc:creator xml:lang="en">Schwark, W.</dc:creator>
	<dc:creator xml:lang="en">Hornbuckle, W.</dc:creator>
	<dc:subject xml:lang="en">verapamil</dc:subject>
	<dc:subject xml:lang="en">oral administration</dc:subject>
	<dc:subject xml:lang="en">intravenous administration</dc:subject>
	<dc:subject xml:lang="en">multidose oral administration</dc:subject>
	<dc:subject xml:lang="en">cats</dc:subject>
	<dc:description xml:lang="en">Pharmacokinetic and electrocardiographic parameters were determined after the administration of single dose oral (S.O.), single dose intravenous (I.V.) and multidose oral (M.O.) verapamil HCâ„“ to healthy cats. The intravenous data were best described by a two compartment open model. Oral data were best described by a one compartment model. The half life of elmination was 1.93, 4.73 and 2.66 hours after I.V., S.O. and M.O. administration. The volume of distribution was identical (2103 ml/kg) after I.V. and S.O. dosing. Bioavailability after S.O. was 29%. In any individual cat, the PR interval varied linearly with the natural log of the plasma concentration of verapamil. However, there was a large interindividual variability in the effects of verapamil on atrioventricular conduction. It was concluded that verapamil could be safely administered to cats on a M.O. or I.V. dosage regimen.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1986-06-10</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/201</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fifth Biennial Symposium; 141-153</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/201/191</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1986 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
